BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 17325041)

  • 1. Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells.
    MacKenzie ED; Selak MA; Tennant DA; Payne LJ; Crosby S; Frederiksen CM; Watson DG; Gottlieb E
    Mol Cell Biol; 2007 May; 27(9):3282-9. PubMed ID: 17325041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.
    Xiao M; Yang H; Xu W; Ma S; Lin H; Zhu H; Liu L; Liu Y; Yang C; Xu Y; Zhao S; Ye D; Xiong Y; Guan KL
    Genes Dev; 2012 Jun; 26(12):1326-38. PubMed ID: 22677546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
    Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
    PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells.
    Selak MA; Durán RV; Gottlieb E
    Biochim Biophys Acta; 2006; 1757(5-6):567-72. PubMed ID: 16797480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
    Hoekstra AS; de Graaff MA; Briaire-de Bruijn IH; Ras C; Seifar RM; van Minderhout I; Cornelisse CJ; Hogendoorn PC; Breuning MH; Suijker J; Korpershoek E; Kunst HP; Frizzell N; Devilee P; Bayley JP; Bovée JV
    Oncotarget; 2015 Nov; 6(36):38777-88. PubMed ID: 26472283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.
    Lehtonen HJ; Mäkinen MJ; Kiuru M; Laiho P; Herva R; van Minderhout I; Hogendoorn PC; Cornelisse C; Devilee P; Launonen V; Aaltonen LA
    Int J Cancer; 2007 Sep; 121(6):1386-9. PubMed ID: 17520677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions.
    Brière JJ; Favier J; Bénit P; El Ghouzzi V; Lorenzato A; Rabier D; Di Renzo MF; Gimenez-Roqueplo AP; Rustin P
    Hum Mol Genet; 2005 Nov; 14(21):3263-9. PubMed ID: 16195397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.
    Selak MA; Armour SM; MacKenzie ED; Boulahbel H; Watson DG; Mansfield KD; Pan Y; Simon MC; Thompson CB; Gottlieb E
    Cancer Cell; 2005 Jan; 7(1):77-85. PubMed ID: 15652751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
    Pollard PJ; Brière JJ; Alam NA; Barwell J; Barclay E; Wortham NC; Hunt T; Mitchell M; Olpin S; Moat SJ; Hargreaves IP; Heales SJ; Chung YL; Griffiths JR; Dalgleish A; McGrath JA; Gleeson MJ; Hodgson SV; Poulsom R; Rustin P; Tomlinson IP
    Hum Mol Genet; 2005 Aug; 14(15):2231-9. PubMed ID: 15987702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF.
    Koivunen P; Hirsilä M; Remes AM; Hassinen IE; Kivirikko KI; Myllyharju J
    J Biol Chem; 2007 Feb; 282(7):4524-4532. PubMed ID: 17182618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer.
    King A; Selak MA; Gottlieb E
    Oncogene; 2006 Aug; 25(34):4675-82. PubMed ID: 16892081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Succinate dehydrogenase/complex II is critical for metabolic and epigenetic regulation of T cell proliferation and inflammation.
    Chen X; Sunkel B; Wang M; Kang S; Wang T; Gnanaprakasam JNR; Liu L; Cassel TA; Scott DA; Muñoz-Cabello AM; Lopez-Barneo J; Yang J; Lane AN; Xin G; Stanton BZ; Fan TW; Wang R
    Sci Immunol; 2022 Apr; 7(70):eabm8161. PubMed ID: 35486677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma.
    Wang Y; Liu B; Li F; Zhang Y; Gao X; Wang Y; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1274239. PubMed ID: 37867526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen concentration controls epigenetic effects in models of familial paraganglioma.
    Her YF; Nelson-Holte M; Maher LJ
    PLoS One; 2015; 10(5):e0127471. PubMed ID: 25985299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
    Laurenti G; Tennant DA
    Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma.
    Smith EH; Janknecht R; Maher LJ
    Hum Mol Genet; 2007 Dec; 16(24):3136-48. PubMed ID: 17884808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended ischemia prevents HIF1alpha degradation at reoxygenation by impairing prolyl-hydroxylation: role of Krebs cycle metabolites.
    Serra-Pérez A; Planas AM; Núñez-O'Mara A; Berra E; García-Villoria J; Ribes A; Santalucía T
    J Biol Chem; 2010 Jun; 285(24):18217-24. PubMed ID: 20368331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the TCA cycle: signaling to tumor formation.
    Raimundo N; Baysal BE; Shadel GS
    Trends Mol Med; 2011 Nov; 17(11):641-9. PubMed ID: 21764377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway.
    Tseng CW; Kuo WH; Chan SH; Chan HL; Chang KJ; Wang LH
    Cancer Res; 2018 Jun; 78(11):2799-2812. PubMed ID: 29599405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-ketoglutarate abrogates the nuclear localization of HIF-1alpha in aluminum-exposed hepatocytes.
    Mailloux RJ; Puiseux-Dao S; Appanna VD
    Biochimie; 2009 Mar; 91(3):408-15. PubMed ID: 19028544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.